India's Manipal Health IPO oversubscribed as institutional demand outweighs retail caution – Reuters

India’s Manipal Health IPO oversubscribed as institutional demand outweighs retail caution  ReutersManipal Hospitals IPO: Should you subscribe or wait?  Value ResearchTemasek-backed Manipal Health IPO fully subscribed on strong institutional demand  VCCircleShould you buy the next IPO? 245 companies waiting to list. Here’s what’s coming  The Economic TimesManipal Health IPO subscribed nearly 5x on last day; latest GMP here  Moneycontrol.

Curated in the public interest from original reporting.
Read full story at Google →